IDEXX Laboratories, Inc.
IDXX
$491.70
$1.720.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 894.97M | 887.87M | 866.24M | 845.63M | 866.57M |
| Total Depreciation and Amortization | 134.10M | 129.94M | 125.97M | 120.82M | 116.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 51.83M | 44.44M | 7.30M | 11.99M | 21.37M |
| Change in Net Operating Assets | -112.51M | -133.24M | -82.68M | -9.25M | -83.24M |
| Cash from Operations | 968.38M | 929.00M | 916.83M | 969.18M | 921.18M |
| Capital Expenditure | -120.68M | -120.92M | -124.22M | -130.23M | -124.39M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 306.00K | -76.69M | -76.69M | -77.00M | -77.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.36M | -9.45M | 3.26M | 9.10M | 8.71M |
| Cash from Investing | -129.73M | -207.06M | -197.65M | -198.12M | -192.69M |
| Total Debt Issued | 69.50M | -- | -- | -- | -- |
| Total Debt Repaid | -75.00M | -75.00M | -150.00M | -87.22M | -254.72M |
| Issuance of Common Stock | 30.81M | 44.49M | 42.57M | 50.19M | 55.12M |
| Repurchase of Common Stock | -1.09B | -847.57M | -638.45M | -452.77M | -237.25M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.26M | -9.39M | -3.14M |
| Cash from Financing | -1.06B | -878.07M | -747.14M | -499.19M | -439.99M |
| Foreign Exchange rate Adjustments | -7.79M | -9.53M | 4.90M | -3.11M | -2.44M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -233.46M | -165.67M | -23.06M | 268.75M | 286.07M |